Early stages of beta-cell deficiency: The "anticipated chronicle" to type 2 diabetes;Les stades précoces du déficit bêta-pancréatique: La "chronique d'un diabète annoncé"

Diabetes and Metabolism

Volumn 29, Issue 2 III, 2003, Pages

  Vialettes, B ^a   Valero R ^a  

^a HÔPITAL SAINTE MARGUERITE   (France)

Author keywords

Insulin resistance; Insulin secretion; Type 2 diabetes mellitus

Indexed keywords

GLUCOSE; INSULIN; PROINSULIN;

CELL FUNCTION; CONFERENCE PAPER; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MARKER; EVALUATION; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HUMAN; HYPERINSULINISM; INDIVIDUALITY; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN RESPONSE; LIVER METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS DISEASE; PANCREAS ISLET BETA CELL; PANCREAS ISLET BETA CELL DEFICIENCY; POPULATION RISK; PREDICTION; PROINSULIN INSULIN RATIO; RISK ASSESSMENT; RISK FACTOR; TIME; PANCREAS ISLET; PATHOPHYSIOLOGY; REVIEW; SECRETION;

DIABETES MELLITUS, TYPE 2; HUMANS; INSULIN; ISLETS OF LANGERHANS; RISK FACTORS;

EID: 0037958343     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (39)

1. Polonsky KS. Evolution of beta-cell dysfunction in impaired glucose tolerance and diabetes. Exp Clin Endocrinol Diabetes, 1999, 107 (Suppl 4), S124-S127.
2. Clark A, Jones LC, de Koning E, Hansen BC, Matthews DR. Decreased insulin secretion in type 2 diabetes: a problem of cellular mass or function? Diabetes, 2001, 50 (Suppl 1), S169-S171.
3. Kahn SE, Prigeon RL, McCulloch DK, et al. Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes, 1993, 42, 1663-72.
4. De Fronzo RA. Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying diabetes genes. Endocr Rev, 1997, 5, 177-269.
5. Ferrannini E. Insulin resistance versus insulin deficiency in non-insulin-dependent diabetes. Endocr Rev, 1998, 19, 477-90.
6. Gerich JE. The genetic basis of type 2 diabetes mellitus: impaired insulin secretion versus impaired insulin sensitivity. Endocr Rev, 1998, 19, 491-503.
7. Kahn SE. The importance of the beta-cell in the pathogenesis of type 2 diabetes mellitus. Am J Med, 2000, 108 Suppl 6a, 2S-8S.
8. Cavaghan MK, Ehrmann DA, Polonsky KS. Interactions between insulin resistance and insulin secretion in the development of glucose intolerance. J Clin Invest, 2000, 106, 329-33.
9. Porte D Jr, Kahn SE. Beta-cell dysfunction and failure in type 2 diabetes: potential mechanisms. Diabetes, 2001, 50 (Suppl 1), S160-S163.
10. Nyholm B, Porksen N, Juhl Cb, et al. Assessment of insulin secretion in relatives of patients with type 2 (non-insulin-dependent) diabetes mellitus: evidence of early beta-cell dysfunction. Metabolism, 2000, 49, 896-905.
11. Perseghin G, Ghosh S, Gerow K, Shulman GI. Metabolic defects in lean nondiabetic offspring of NIDDM parents: a cross-sectional study. Diabetes, 1997, 46, 1001-9.
12. Cerasi E, Luft R, Efendic S. Decreased sensitivity of the pancreatic beta-cells to glucose in prediabetic and diabetic subjects. A glucose dose-response study. Diabetes, 1972, 21, 224-34.
13. Vague P, Ramahandridona G, Vialettes B, Raymond JP, Vague J. Defective acute insulin secretion in diabetics. Differences between normal weight and obese subjects. Diabetes Metab, 1978, 4, 261-5.
14. Pimenta W, Korytkowski M, Mitrakou A, et al. Pancreatic beta-cell dysfunction as the primary genetic lesion in NIDDM. Evidence from studies in normal glucose-tolerant individuals with a first-degree NIDDM relative. JAMA, 1995, 273, 1855-61.
15. Alford FP, Henriksen JE, Rantzau C, et al. Impact of family history of diabetes on the assessment of beta-cell function. Metabolism, 1998, 47, 522-8.
16. Vauhkonen I, Niskanen L, Vanninen E, Kainulainen S, Uusitupa M, Laakso M. Defects in insulin secretion and insulin action in non-insulin-dependent diabetes mellitus are inherited. Metabolic studies on offspring of diabetic probands. J Clin Invest, 1998, 101, 86-96.
17. Vauhkonen IK, Niskanen LK, Mykkanen L, Haffner SM, Uusitupa MI, Laakso M. Hyperproinsulinemia is not a characteristic feature in the offspring of patients with different phenotypes of type II diabetes. Eur J Endocrinol, 2000, 43, 251-60.
18. Veening MA, van Weissenbruch MM, Delemarre-van de Waal HA. Glucose tolerance, insulin sensitivity, and insulin secretion in children born small for gestational age. J Clin Endocrinol Metab, 2002, 87, 4657-61.
19. Jaquet D, Gaboriau A, Czernichow P, Levy-Marchal C. Insulin resistance early in adulthood in subjects born with intrauterine growth retardation. J Clin Endocrinol Metab, 2000, 85, 1401-6.
20. Swinburn BA, Gianchandani R, Saad MF, Lillioja S. In vivo beta-cell function at the transition to early non-insulin-dependent diabetes mellitus. Metabolism 1995, 44, 757-64.
21. Beer SF, O'Rahilly S, Spivey RS, Hales CN, Turner RC. Plasma proinsulin in first-degree relatives of type 2 diabetic subjects. Diabetes Res, 1990, 14, 51-4.
22. Stumvoll M, Fritsche A, Stefan N, Hardt E, Haring H. Evidence against a rate-limiting role of proinsulin processing for maximal insulin secretion in subjects with impaired glucose tolerance and beta-cell dysfunction. J Clin Endocrinol Metab, 2001, 86, 1235-9.
23. Birkeland KI, Torjesen PA, Eriksson J, Vaaler S, Groop L. Hyperproinsulinemia of type II diabetes is not present before the development of hyperglycemia. Diabetes Care, 1994, 17, 1307-10.
24. O'Meara NM, Sturis J, van Cauter E, Polonsky KS. Lack of control by glucose of ultradian insulin secretory oscillations in impaired glucose tolerance and in non-insulin-dependent diabetes mellitus. J Clin Invest, 1993, 92, 262-71.
25. Vague P, Ramahandridona G, Gerolami A. Insulin response to glucose and tolbutamide in "essential" versus "pancreatic" mild glucose intolerance. Diabetes, 1974, 23, 896-901.
26. Owens DR, Luzio SD, Coates PA. Insulin secretion and sensitivity in newly diagnosed NIDDM Caucasians in the UK. Diabet Med, 1996, 13 (Suppl 6), S19-S24.
27. Mykäanen L, Zaccaro DJ, Hales CN, Festa A, Haffner SM. The relation of proinsulin and insulin to insulin sensitivity and acute insulin response in subjects with newly diagnosed type II diabetes: the Insulin Resistance Atherosclerosis Study. Diabetologia, 1999, 42, 1060-6.
28. UK Prospective Diabetes Study Group. UK Prospective Diabetes Study 16. Overview of 6 years'therapy of diabetes: a progressive disease. Diabetes, 1995, 44, 1249-58.
29. Turner R, Stratton I, Horton V, et al. UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group. Lancet, 1997, 350, 1288-93.
30. Pozzilli P, Di Mario U. Autoimmune diabetes not requiring insulin at diagnosis (latent autoimmune diabetes of the adult): definition, characterization, and potential prevention. Diabetes Care, 2001, 24, 1460-7.
31. Lillioja S, Mott DM, Spraul M, et al. Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians. N Engl J Med, 1993, 329, 1988-92.
32. Weyer C, Bogardus C, Mott DM, Pratley RE. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest, 1999, 104, 787-94.
33. Weyer C, Bogardus C, Mott DM, Pratley RE. Insulin resistance and insulin secretory dysfunction are independent predictors of worsening of glucose tolerance during each stage of type 2 diabetes development. Diabetes Care, 2001, 24, 89-94.
34. Pratley RE, Weyer C. The role of impaired early insulin secretion in the pathogenesis of Type II diabetes mellitus. Diabetologia, 2001, 44, 929-45.
35. Weyer C, Hanson RL, Tataranni PA, Bogardus C, Pratley RE. A high fasting plasma insulin concentration predicts type 2 diabetes independent of insulin resistance: evidence for a pathogenic role of relative hyperinsulinemia. Diabetes, 2000, 49, 2094-101.
36. Haffner SM, Gonzalez C, Mykkänen L, Stern M. Total immunoreactive proinsulin, immunoreactive insulin and specific insulin in relation to conversion to NIDDM: the Mexico City Diabetes Study. Diabetologia, 1997, 40, 830-7.
37. Wareham NJ, Byrne CD, Williams R, Day NE, Hales CN. Fasting proinsulin concentrations predict the development of type 2 diabetes. Diabetes Care, 1999, 22, 262-70.
38. Wareham NJ, Byrne CD, Williams R, Day NE, Hales CN. Proinsulin levels predict the development of non-insulin-dependent diabetes mellitus (NIDDM) in Japanese-American men. Diabet Med, 1996, 13 (Suppl 6), S63-S66.
39. Nijpels G, Popp-Snijders C, Kostense PJ, Bouter LM, Heine RJ. Cardiovascular risk factors prior to the development of non-insulin-dependent diabetes mellitus in persons with impaired glucose tolerance: the Hoorn Study. J Clin Epidemiol, 1997, 50, 1003-9.